Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years With Presumed Immunocompromised Status
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
MMWR. Morbidity and Mortality Weekly Report
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status - United States, January 12, 2022-March 28, 2022
MMWR Morb. Mortal. Wkly. Rep. 2022 Jul 15;71(28)899-903, AM Hause, J Baggs, P Marquez, WE Abara, JG Baumblatt, D Thompson, JR Su, TR Myers, J Gee, TT Shimabukuro, DK ShayFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.